TABLE 1.

Patient Demographics

Demographic	Data
Total number of patients	42
1 dose	20
2 doses	22
Primary malignancy
Neuroblastoma	32
Medulloblastoma	2
Sarcoma	3
Ependymoma	1
Rhabdoid tumor	1
Melanoma	1
Chordoma	1
Choroid plexus tumor	1
Age range	3 mo–42 y
Sex
Male	26
Female	16

Data are n, except for age.